ABAL Therapeutics

The Team

Shamus Roeder
MS, Biomedical Engineering, 2019
Logan Grote
Computer Science, Entrepreneurial Management, 2018
Max Salinger
Computer Science and Linguistics, 2020

ABAL Therapeutics is dedicated to bringing high quality therapeutic care to every child affected by autism. Today, waitlists often exceed 18 months, costs can exceed $100K each year, and fewer than 30% of families have access to behavioral therapy. By delivering therapy through a digital platform, ABAL is making behavioral therapy a possibility for the more than 700,000 children affected by autism in the US.